false
--12-31
0001267602
0001267602
2024-09-16
2024-09-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13
OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
September 16, 2024
ALIMERA SCIENCES, INC.
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-34703 |
|
20-0028718 |
(State
or other Jurisdiction of
Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer Identification No.) |
6310 Town Square, Suite 400
Alpharetta, Georgia |
|
30005 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (678) 990-5740
Not Applicable
(Former name or former address if
changed since
last report.)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, $0.01 par value per share |
|
ALIM |
|
The Nasdaq
Stock Market LLC
(Nasdaq Global Market) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Introduction
On June 21, 2024, Alimera Sciences, Inc., a Delaware
corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”)
with ANI Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and ANIP Merger Sub Inc.,
a Delaware corporation and wholly owned indirect subsidiary of Parent (“Merger Subsidiary”), providing for the
merger of Merger Subsidiary with and into the Company (the “Merger”), with the Company surviving the Merger
as a wholly owned indirect subsidiary of Parent. Capitalized terms not otherwise defined have the meanings set forth in the Merger Agreement.
On September 16, 2024, upon the terms and subject
to the conditions set forth in the Merger Agreement and in accordance with the applicable provisions of the General Corporation Law of
the State of Delaware, the Merger was completed. At the Effective Time of the Merger, the separate corporate existence of Merger Subsidiary
ceased and the Company survived the Merger as a wholly owned indirect subsidiary of Parent.
Item 1.02. Termination of Material Definitive Agreement.
Effective as of September 16, 2024, and contingent
upon the consummation of the Merger, the Company terminated the Company’s 2010 Employee Stock Purchase Plan, as amended.
In connection with the completion of the Merger,
on the Closing Date, Parent, on behalf of the Company, repaid in full all indebtedness, liabilities and other obligations outstanding
under, and terminated, (i) that certain Loan and Security Agreement dated as of December 31, 2019 (as amended, restated, amended and restated,
modified, or otherwise supplemented from time to time prior to the date hereof) by and among the Company, SLR Investment Corp., a Maryland
corporation (formerly known as Solar Capital Ltd.) (“SLR”), as collateral agent and a lender, and any other
lenders party thereto from time to time, (ii) the Exit Fee Agreement, dated as of January 5, 2018, by and among the Company, SLR, as the
collateral agent and a lender, and the other lenders party thereto (as amended, restated, amended and restated, supplemented, or otherwise
modified from time to time), (iii) the Exit Fee Agreement, dated as of December 31, 2019, by and among the Company, SLR, as the collateral
agent and a lender, and the other lenders party thereto (as amended, restated, amended and restated, supplemented, or otherwise modified
from time to time), (iv) the Fifth Amendment Exit Fee Agreement, dated as of March 24, 2023, by and among the Company, SLR, as the collateral
agent and a lender, and the other lenders party thereto (as amended, restated, amended and restated, supplemented, or otherwise modified
from time to time), and (v) the Third Amended and Restated Fee Letter, dated March 6, 2024, by and among the Company, SLR, as the collateral
agent and a lender, and the other lenders party thereto (as amended, restated, amended and restated, supplemented, or otherwise modified
from time to time).
Item 2.01. Completion of Acquisition or Disposition of Assets.
The information set forth in the Introduction
to this Current Report on Form 8-K (the “Introduction”) is incorporated into this Item 2.01 by reference.
At the effective time of the Merger (the “Effective
Time”), each share of common stock, par value $0.01 per share, of the Company (the “Company Common Stock”)
outstanding immediately prior to the Effective Time (including each Company RSA (as defined below) but excluding any treasury shares or
shares owned by Parent, Merger Subsidiary or any other subsidiary of Parent or the Company), was canceled and ceased to exist and was
converted into the right to receive (i) $5.50 in cash, without interest (such amount, as may be adjusted in accordance with the Merger
Agreement, the “Closing Cash Consideration”) and (ii) one contingent value right (a “CVR”),
which represents the right to receive the Milestone Payments (as defined below) subject to the terms and conditions set forth in the CVR
Agreement (as defined below) (the consideration contemplated by (i) and (ii), together, the “Merger Consideration”).
At the Effective Time, outstanding awards of restricted
stock with respect to shares of Company Common Stock (each, a “Company RSA”), whether vested or unvested as
of immediately prior to the Effective Time, for which the holder thereof made a timely and valid election (an “83(b) Election”)
under Section 83(b) of the Internal Revenue Code of 1986, as amended, were cancelled and ceased to exist, and were converted
into the right to receive the Merger Consideration.
At the Effective Time, each Company RSA for which
the holder thereof did not make a timely and valid 83(b) Election was canceled and converted into the right to receive (i) an
amount in cash (without interest and subject to deduction for any required withholding as contemplated by the Merger Agreement) equal
to: (A) the total number of shares of such Company RSAs multiplied by (B) the Closing Cash Consideration, without any interest
thereon, and (ii) CVRs in an amount equal to the total number of shares of such Company RSAs.
At the Effective Time, each stock option granted
by the Company to purchase Company Common Stock (each, a “Company Option”) that was outstanding and unvested
immediately prior to the Effective Time vested in full, and (i) each Company Option then outstanding and unexercised and which had
a per share exercise price that was less than the Closing Cash Consideration was canceled and converted into the right to receive the
sum of an amount in cash (without interest and subject to deduction for any required withholding as contemplated in the Merger Agreement)
equal to: (a) the excess, if any, of the Closing Cash Consideration over the exercise price per share of such Company Option; multiplied
by the number of shares of Company Common Stock underlying such Company Option and (b) one (1) CVR, (ii) each Company Option
then outstanding and unexercised, and which had a per share exercise price that equaled or exceeded the Closing Cash Consideration, but
was less than the Maximum Total Consideration (as defined in the Merger Agreement) (each, an “Eligible Option”)
was canceled and converted into the right to receive a cash payment equal to (a) the excess, if any, of (A) the Total Consideration
(as defined in the Merger Agreement) over (B) the per share exercise price of such Eligible Option, multiplied by (b) the total
number of shares of Company Common Stock subject to such Eligible Option immediately prior to the Effective Time, and (iii) each
Company Option then outstanding and unexercised and that had a per share exercise price that was equal or greater than the Maximum Total
Consideration was canceled with no consideration payable in respect thereof.
At the Effective Time, each Company performance
stock unit (“Company PSU”) then outstanding was automatically canceled and converted into the right to receive
(i) from the Surviving Corporation an amount of cash equal to the product of (A) the total number of shares of Company Common
Stock underlying such Company PSUs pursuant to the applicable Company PSU grant terms, with, for the avoidance of doubt, all performance
metrics deemed achieved at 100%, multiplied by (B) the Closing Cash Consideration, without any interest thereon and (ii) CVRs
in an amount equal to the total number of shares of Company Common Stock then underlying such Company PSUs pursuant to the applicable
Company PSU grant terms, with, for the avoidance of doubt, all performance metrics deemed achieved at 100%.
At the Effective Time, each Company restricted
stock unit (“Company RSU”) then outstanding was automatically canceled and converted into the right to receive
(i) from the Surviving Corporation an amount of cash equal to the product of (A) the number of shares of Company Common Stock
underlying such Company RSU multiplied by (B) the Closing Cash Consideration, without any interest thereon and (ii) CVRs in
an amount equal to the total number of shares of Company Common Stock then underlying such Company RSUs.
The description of the Merger set forth above
does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement, which was filed by the Company
as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on June 24, 2024.
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
The information set forth in the Introduction
and under Item 2.01 is incorporated herein by reference.
On September 16, 2024, in connection with
the consummation of the Merger, the Company requested that The Nasdaq Global Market suspend trading of the Company Common Stock and file with the Securities and Exchange Commission (the “SEC”) a Notification
of Removal from Listing and/or Registration on Form 25 to delist and deregister the shares of the Company common stock under Section
12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company intends to file
with the SEC a certification on Form 15 requesting that the Company’s reporting obligations under Sections 13 and 15(d) of the
Exchange Act be suspended.
Item 3.03. Material Modification to Rights of Security Holders.
The information set forth in the Introduction and under Item 2.01,
Item 3.01 and Item 5.01 is incorporated herein by reference.
Item 5.01. Changes in Control of Registrant.
The information set forth in the Introduction is incorporated in this
Item 5.01 by reference.
As a result of the consummation of the Merger, a change of control
of the Company occurred, and the Company became a wholly owned subsidiary of Parent. Parent obtained the funds necessary to fund the
Merger through a variety of sources, including incremental financing and cash on hand.
Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
The information set forth under Item 2.01 is incorporated herein by
reference.
In connection with the consummation of the Merger,
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko
ceased to be members of the Board of Directors of the Company (the “Company Board”) and ceased to be members
of any committees of the Company Board on which such directors served, effective as of the Effective Time. On September 16, 2024, in connection
with the consummation of the Merger, the directors of Merger Subsidiary became the directors of the Surviving Corporation in lieu of the
Company’s existing directors.
In connection with the consummation of the Merger, each officer of
the Company immediately prior to the Effective Time became an officer of the Surviving Corporation.
Item 5.03. Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year.
The information set forth in the Introduction
and under Item 2.01 is incorporated herein by reference.
Effective upon completion of the Merger, the
certificate of incorporation of Merger Subsidiary, as in effect immediately prior to the Merger, became the certificate of incorporation
of the Surviving Corporation (except that all references to the name of Merger Subsidiary therein were modified to refer to the name of
the Company) (the “Amended and Restated Certificate”).
Effective upon completion of the Merger, the bylaws
of Merger Subsidiary, as in effect immediately prior to the Merger, became the bylaws of the Surviving Corporation (except that all references
to the name of Merger Subsidiary therein were modified to refer to the name of the Company) (the “Amended and Restated Bylaws”).
The foregoing descriptions of the Amended and
Restated Certificate and Amended and Restated Bylaws are qualified in their entirety by reference to the full text of the Amended and
Restated Certificate and Amended and Restated Bylaws, copies of which are filed as Exhibit 3.1 and Exhibit 3.2 to this Current Report
on Form 8-K, respectively, and are incorporated herein by reference.
Item 8.01. Other Events.
Contingent Value Rights Agreement
At the Effective Time, Parent entered into a contingent
value rights agreement (the “CVR Agreement”) with a rights agent (the “Rights Agent”),
pursuant to which each holder of Company Common Stock, as well as holders of Company warrants, Company Options, Company PSUs, Company
RSAs and Company RSUs, may become entitled to contingent cash payments per CVR (each, a “Milestone Payment”),
such payments being contingent upon, and subject to, the achievement of: (i) $140.0 million in net revenue (the “2026
Milestone”) on third party sales of ILUVIEN® and YUTIQ® for Parent’s 2026 fiscal year (the “2026
Net Revenue”) and/or (ii) $160.0 million in net revenue (the “2027 Milestone” and together
with the 2026 Milestone, the “Milestones”) on third party sales of ILUVIEN® and YUTIQ® for Parent’s
2027 fiscal year (the “2027 Net Revenue”).
Each CVR entitles the holder (the “Holder”)
to receive a Milestone Payment upon satisfaction of the applicable Milestones. The Milestone Payment for each CVR will equal the product
(rounded to the nearest 1/100 of $0.01) of (i) $0.25 multiplied by a fraction (not exceeding one), the numerator of which is the
amount, if any, by which the 2026 Net Revenue exceeds $140.0 million and the denominator of which is $10.0 million (subject to adjustment
for the exercise price of Eligible Options) and/or (ii) $0.25 multiplied by a fraction (not exceeding one), the numerator of which
is the amount, if any, by which the 2027 Net Revenue exceeds $160.0 million and the denominator of which is $15.0 million (subject to
adjustment for the exercise price of Eligible Options).
If a Milestone is attained, the distributions
in respect of the CVRs will be made on or prior to the date that is fifteen (15) business days following the filing by Parent of its audited
financial statements with the SEC on Form 10-K in respect of the applicable year in which such Milestone has been achieved, and will
be subject to a number of deductions, exceptions and limitations, including but not limited to certain taxes.
Under the CVR Agreement, the Rights Agent will
have, and Holders of at least 35% of the CVRs then-outstanding have, certain rights to audit and enforcement on behalf of all Holders
of the CVRs. Parent will undertake under the terms of the CVR Agreement to use diligent efforts to achieve the Milestones, as such efforts
are further described in the CVR Agreement.
The foregoing description of the CVR Agreement
does not purport to be complete and is qualified in its entirety by reference to the full text of the form of the CVR Agreement, a form
of which is included as Exhibit B to the Merger Agreement, which is filed as Exhibit 2.1 to the Current Report on Form 8-K
filed on June 24, 2024 and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ALIMERA SCIENCES, INC. |
|
|
Dated: September 16, 2024 |
By: |
/s/ Richard S. Eiswirth, Jr. |
|
Name: |
Richard S. Eiswirth, Jr. |
|
Title: |
President and Chief Executive Officer |
Exhibit 3.1
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
ALIMERA
SCIENCES, INC.
FIRST: The name
of the corporation is:
ALIMERA
SCIENCES, INC.
SECOND: The address
of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, County
of New Castle. The name of its registered agent at such address is The Corporation Trust Company.
THIRD: The nature
of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized
under the Delaware General Corporation Law.
FOURTH: The total
number of shares of stock which the corporation shall have authority to issue is 1,000 shares of common stock, par value $0.01 per share.
FIFTH: The corporation
is to have perpetual existence.
SIXTH: In furtherance
and not in limitation of the powers conferred by the laws of the State of Delaware:
A. the
board of directors of the corporation is expressly authorized to adopt, amend or repeal the bylaws of the corporation;
B. elections
of directors need not be by written ballot unless the bylaws of the corporation shall so provide;
C. the
books of the corporation may be kept at such place within or without the State of Delaware as the bylaws of the corporation may provide
or as may be designated from time to time by the board of directors of the corporation; and
D. any
action required or permitted to be taken at any meeting of the board of directors of the corporation may be taken without a meeting only
if all of the directors consent thereto in writing.
SEVENTH: To the
fullest extent permitted by law of the State of Delaware, no director or officer shall be personally liable to the corporation or the
holders of shares of capital stock for monetary damages for breach of fiduciary duty as a director or officer.
No amendment to or repeal of this provision shall
apply to or have any effect on the liability or alleged liability of any director or officer for or with respect to any acts or omissions
of such director or officer occurring prior to such amendment or repeal. If the law of the State of Delaware is hereafter amended to authorize
corporate action further eliminating or limiting the personal liability of directors or officers, then the liability of a director or
officer of the corporation shall be eliminated or limited to the fullest extent then permitted. No repeal or modification of this Article SEVENTH
shall adversely affect any right of or protection afforded to a director or officer of the corporation existing immediately prior to such
repeal or modification.
EIGHTH: The corporation
shall indemnify and may advance expenses to its officers and directors to the fullest extent permitted by law either now in existence
or hereafter in effect. Without limiting the generality of the foregoing, the bylaws of the corporation may provide for indemnification
and advancement of expenses to the corporation's officers, directors, employees and agents on such terms and conditions as the board of
directors of the corporation may from time to time deem appropriate or advisable.
NINTH: Except
as provided herein, from time to time any of the provisions of this Certificate of Incorporation may be amended, altered or repealed,
and other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner and
at the time prescribed by said laws, and all rights at any time conferred upon the stockholders of the corporation by this certificate
of incorporation are granted subject to the provisions of this Article NINTH.
Exhibit 3.2
AMENDED AND RESTATED BY-LAWS
OF
Alimera
Sciences, Inc.
A Delaware Corporation
ARTICLE I
OFFICES
Section 1. Registered
Office. The registered office of the corporation in the State of Delaware shall be located at 1209 Orange Street, in the city
of Wilmington, County of New Castle 19801. The name of the corporation's registered agent at such address shall be The Corporation Trust
Company. The registered office and/or registered agent of the corporation may be changed from time to time by action of the Board of
Directors.
Section 2. Other
Offices. The corporation may also have offices at such other places, both within and without the State of Delaware, as the
Board of Directors may from time to time determine or the business of the corporation may require.
ARTICLE II
MEETINGS OF STOCKHOLDERS
Section 1. Place
and Time of Meetings. The date, time and place of the annual meeting shall be determined by the Board of Directors of the
corporation.
Section 2. Special
Meetings. Special meetings of stockholders may be called for any purpose and may be held at such time and place, within or
outside of the State of Delaware, as shall be stated in a notice of meeting or in a duly executed waiver of notice thereof. Except as
otherwise provided in the certificate of incorporation, such meetings may only be called upon the written request of holders of shares
entitled to cast not less than fifty percent of the votes at the meeting. Such written request shall state the purpose or purposes of
the meeting and shall be delivered to the highest ranking officer then in office (the "Ranking Officer"). On such written
request, the Ranking Officer shall fix a date and time for such meeting within two (2) days of the date requested for such meeting
in such written request. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice.
Section 3. Place
of Meetings. The Board of Directors may designate any place, either within or outside of the State of Delaware, as the place
of meeting for any annual meeting or for any special meeting. If no designation is made, the place of meeting shall be the principal
executive office of the corporation.
Section 4. Notice.
Whenever stockholders are required or permitted to take action at a meeting, written or printed notice stating the place, date, time,
and, in the case of special meetings, the purpose or purposes, of such meeting, shall be given to each stockholder entitled to vote at
such meeting not less than 10 nor more than 60 days before the date of the meeting. All such notices shall be delivered, either personally
or by mail, by or at the direction of the Board of Directors, the Chief Executive Officer or the Secretary, and if mailed, such notice
shall be deemed to be delivered when deposited in the United States mail, postage prepaid, addressed to the stockholder at his, her or
its address as the same appears on the records of the corporation. Attendance of a person at a meeting shall constitute a waiver of notice
of such meeting, except when the person attends for the express purpose of objecting at the beginning of the meeting to the transaction
of any business because the meeting is not lawfully called or convened.
Section 5. Stockholders
List. The officer having charge of the stock ledger of the corporation shall make, at least 10 days before every meeting of
the stockholders, a complete list of the stockholders entitled to vote at such meeting arranged in alphabetical order, showing the address
of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of
any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least 10 days prior to the
annual meeting at the place where the meeting is to be held. The list shall also be produced and kept at the time and place of the meeting
during the whole time thereof, and may be inspected by any stockholder who is present.
Section 6. Quorum.
The holders of a majority of the outstanding shares of capital stock entitled to vote, present in person or represented by proxy, shall
constitute a quorum at all meetings of the stockholders, except as otherwise provided by statute or by the certificate of incorporation.
If a quorum is not present, the holders of a majority of the shares of capital stock present in person or represented by proxy at the
meeting, and entitled to vote at the meeting, may adjourn the meeting to another time and/or place.
Section 7. Conduct
of Meetings. The Chairman, if any, and, in his absence or discretion, any person chosen by the stockholders present shall
call the meeting of the stockholders to order and shall act as chairman of the meeting, and the Secretary of the corporation shall act
as secretary of all meetings of the stockholders, but, in the absence or upon the request of the Secretary, the presiding officer may
appoint any other person to act as secretary of the meeting.
Section 8. Adjourned
Meetings. When a meeting is adjourned to another time and place, notice need not be given of the adjourned meeting if the
time and place thereof are announced at the meeting at which the adjournment is taken. At the adjourned meeting the corporation may transact
any business which might have been transacted at the original meeting. If the adjournment is for more than thirty days, or if after the
adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder
of record entitled to vote at the meeting.
Section 9. Vote
Required. When a quorum is present, the affirmative vote of the majority of shares present in person or represented by proxy
at the meeting and entitled to vote on the subject matter shall be the act of the stockholders, unless the question is one upon which
by express provisions of an applicable law or of the certificate of incorporation a different vote is required, in which case such express
provision shall govern and control the decision of such question.
Section 10. Voting
Rights. Except as otherwise provided by the General Corporation Law of the State of Delaware or by the certificate of incorporation
of the corporation or any amendments thereto and subject to Section 3 of Article VI hereof, every stockholder shall at every
meeting of the stockholders be entitled to one vote in person or by proxy for each share of common stock held by such stockholder and
no votes for any other class or series of capital stock held by such stockholder.
Section 11. Proxies.
Each stockholder entitled to vote at a meeting of stockholders or to express consent or dissent to corporate action in writing without
a meeting may authorize another person or persons to act for him, her or it by proxy, but no such proxy shall be voted or acted upon
after three years from its date, unless the proxy provides for a longer period.
Section 12. Action
by Written Consent. Unless otherwise provided in the certificate of incorporation, any action required to be taken at any
annual or special meeting of stockholders of the corporation, or any action which may be taken at any annual or special meeting of such
stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth
the action so taken and bearing the dates of signature of the stockholders who signed the consent or consents, shall be signed by the
holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action
at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the corporation by delivery
to its registered office in the state of Delaware, or the corporation's principal place of business, or an officer or agent of the corporation
having custody of the book or books in which proceedings of meetings of the stockholders are recorded. Delivery made to the corporation's
registered office shall be by hand or by certified or registered mail, return receipt requested. All consents properly delivered in accordance
with this section shall be deemed to be recorded when so delivered. No written consent shall be effective to take the corporate action
referred to therein unless, within sixty days of the earliest dated consent delivered to the corporation as required by this section,
written consents signed by the holders of a sufficient number of shares to take such corporate action are so recorded. Prompt notice
of the taking of the corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who
have not consented in writing and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if
the record date for such meeting had been the date that written consents signed by a sufficient number of holders to take the action
were delivered to the corporation. Any action taken pursuant to such written consent or consents of the stockholders shall have the same
force and effect as if taken by the stockholders at a meeting thereof.
ARTICLE III
DIRECTORS
Section 1. General
Powers. The business and affairs of the corporation shall be managed by or under the direction of the Board of Directors.
Section 2. Number,
Election and Term of Office. The Board of Directors of the corporation shall consist of that number of directors as determined
from time to time by the Board of Directors, but shall in no event exceed ten. The directors shall be elected by a plurality of the votes
of the shares present in person or represented by proxy at the meeting and entitled to vote in the election of directors. The directors
shall be elected in this manner at the annual meeting of the stockholders, except as provided in Section 4 of this Article III.
Each director elected shall hold office until a successor is duly elected and qualified or until his or her earlier death, resignation
or removal as hereinafter provided. The provisions contained in this Article III shall be subject to the terms and conditions of
any stockholders agreement then in effect by and among the corporation and any of its stockholders (the "Stockholders Agreements")
and the certificate of incorporation.
Section 3. Removal
and Resignation. Subject to the provisions of the Stockholders Agreements, any director or the entire Board of Directors may
be removed at any time, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors.
Whenever the holders of any class or series are entitled to elect one or more directors by the provisions of the corporation's certificate
of incorporation or the Stockholders Agreements, the provisions of this section shall apply, in respect to the removal without cause
of a director or directors so elected, to the vote of the holders of the outstanding shares of that class or series and not to the vote
of the outstanding shares as a whole. Any director may resign at any time upon written notice to the corporation.
Section 4. Vacancies.
Subject to the provisions of the Stockholders Agreements, vacancies and newly created directorships resulting from any increase in the
authorized number of directors may be filled by the remaining Board of Directors, even if less than a quorum. Each director so chosen
shall hold office until a successor is duly elected and qualified or until his or her earlier death, resignation or removal as herein
provided.
Section 5. Annual
Meetings. An annual meeting of the Board of Directors may be held without other notice than this by-law immediately after,
and at the same place as, the annual meeting of stockholders.
Section 6. Other
Meetings and Notice. Regular meetings, other than the annual meeting, of the Board of Directors may be held without notice
at such time and at such place as shall from time to time be determined by resolution of the board. Special meetings of the Board of
Directors may be called by or at the request of the Ranking Officer on at least twenty-four (24) hours notice to each director, either
personally, by telephone, by mail, or by facsimile; in like manner and on like notice the Ranking Officer must call a special meeting
on the written request of at least two of the directors.
Section 7. Quorum,
Required Vote and Adjournment. Each director shall be entitled to one vote except as otherwise provided in the certificate
of incorporation. Directors then in office (and specifically excluding any vacancies) holding a majority of the votes of all directors
(or such greater number required by applicable law) shall constitute a quorum for the transaction of business. The vote of directors
holding a majority of votes present at a meeting at which a quorum is present shall be the act of the Board of Directors. If a quorum
shall not be present at any meeting of the Board of Directors, the directors present thereat may adjourn the meeting from time to time,
without notice other than announcement at the meeting, until a quorum shall be present.
Section 8. Conduct
of Meetings. The Chairman, if any, and, in his absence or discretion, any person chosen by the directors present shall call
meetings of the Board of Directors to order and shall act as chairman of the meeting. The Secretary of the corporation shall act as secretary
of all meetings of the Board of Directors, but, in the absence or upon the request of the Secretary, the presiding officer may appoint
any other person to act as secretary of the meeting.
Section 9. Committees.
The Board of Directors may, by resolution passed by a majority of the whole board, designate one or more committees, each committee to
consist of one or more of the directors of the corporation, which to the extent provided in such resolution or these by-laws shall have
and may exercise the powers of the Board of Directors in the management and affairs of the corporation except as otherwise limited by
law. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or
disqualified member at any meeting of the committee. Such committee or committees shall have such name or names as may be determined
from time to time by resolution adopted by the Board of Directors. Each committee shall keep regular minutes of its meetings and report
the same to the Board of Directors when required.
Section 10. Committee
Rules. Each committee of the Board of Directors may fix its own rules of procedure and shall hold its meetings as provided
by such rules, except as may otherwise be provided by a resolution of the Board of Directors designating such committee.
Section 11. Communications
Equipment. Members of the Board of Directors or any committee thereof may participate in and act at any meeting of such board
or committee through the use of a conference telephone or other communications equipment by means of which all persons participating
in the meeting can hear each other, and participation in the meeting pursuant to this section shall constitute presence in person at
the meeting.
Section 12. Waiver
of Notice and Presumption of Consent. Any member of the Board of Directors or any committee thereof who is present at a meeting
shall be conclusively presumed to have waived notice of such meeting except when such member attends for the express purpose of objecting
at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened. Such member
shall be conclusively presumed to have consented to any action taken unless his or her dissent shall be entered in the minutes of the
meeting or unless his or her written dissent to such action shall be filed with the person acting as the secretary of the meeting before
the adjournment thereof or shall be forwarded by registered mail to the Secretary of the corporation immediately after the adjournment
of the meeting. Such right to dissent shall not apply to any member who voted in favor of such action.
Section 13. Action
by Written Consent. Unless otherwise restricted by the certificate of incorporation, any action required or permitted to be
taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting if all members of the board
or committee, as the case may be, consent thereto in writing, and the writing or writings are filed with the minutes of proceedings of
the board or committee.
ARTICLE IV
OFFICERS
Section 1. Number.
The officers of the corporation shall be elected by the Board of Directors and may consist of a chief executive officer, a president,
any number of vice presidents, a secretary, any number of assistant secretaries, a treasurer, any number of assistant treasurers and
such other officers and assistant officers as may be deemed necessary or desirable by the Board of Directors. Any number of offices may
be held by the same person. In its discretion, the Board of Directors may choose not to fill any office for any period as it may deem
advisable, except that the offices of chief executive officer, president and secretary shall be filled as expeditiously as possible.
Section 2. Election
and Term of Office. The officers of the corporation shall be elected annually by the Board of Directors at its first meeting
held after each annual meeting of stockholders or as soon thereafter as conveniently may be. Vacancies may be filled or new offices created
and filled at any meeting of the Board of Directors. Each officer shall hold office until a successor is duly elected and qualified or
until his or her earlier death, resignation or removal as hereinafter provided.
Section 3. Removal.
Any officer or agent elected by the Board of Directors may be removed by the Board of Directors whenever in its judgment the best interests
of the corporation would be served thereby, but such removal shall be without prejudice to the contract rights, if any, of the person
so removed.
Section 4. Vacancies.
Any vacancy occurring in any office because of death, resignation, removal, disqualification or otherwise, may be filled by the Board
of Directors for the unexpired portion of the term by the Board of Directors then in office.
Section 5. Compensation.
Compensation of all officers shall be fixed by the Board of Directors, and no officer shall be prevented from receiving such compensation
by virtue of his or her also being a director of the corporation.
Section 6. Chairman
of the Board. The Chairman of the Board, if one be chosen by the Board of Directors, shall preside at all meetings of the
Board of Directors and of the stockholders and shall perform all duties incident to the office of the Chairman of the Board of the corporation
and such other duties as may be prescribed by the Board of Directors from time to time. In the event that any member of the Board disagrees
with the manner in which the Chairman of the Board is discharging the duties incident to the office of the Chairman of the Board, such
member shall have the right to call a vote of the Board of Directors, the vote of a majority of whom shall prevail.
Section 7. Chief
Executive Officer. The Board of Directors may from time to time designate the Chairman of the Board, if any, or the President
of the corporation as the Chief Executive Officer of the corporation. The President shall be the Chief Executive Officer whenever the
office of Chairman of the Board of the corporation is vacant. The Board of Directors may also designate the Chairman of the Board, if
any, and any officer of the corporation as Co-Chief Executive Officers, each individually authorized to perform all duties of the Chief
Executive Officer set forth herein. Subject to the control of the Board of Directors, the Chief Executive Officer shall in general supervise
and control all of the business and affairs of the corporation. He or she shall have authority, subject to such rules as may be
prescribed by the Board of Directors, to appoint and remove such agents and employees of the corporation as he or she shall deem necessary
to prescribe their powers, duties and compensation, and to delegate authority to them. He or she shall have authority to sign, execute
and acknowledge, on behalf of the corporation, all deeds, mortgages, securities, contracts, leases, reports, and all other documents
or other instruments necessary or proper to be executed in the course of the corporation's regular business, or which shall be authorized
by resolution of the Board of Directors; and, except as otherwise provided by law or the Board of Directors, he or she may authorize
any elected President, Vice President or other officer or agent of the corporation to sign, execute and acknowledge such documents or
instruments in his or her place and stead. In general, he or she shall perform all duties incident to the office of Chief Executive Officer
of the corporation and such other duties as may be prescribed by the Board of Directors from time to time.
Section 8. President.
Unless the Board of Directors otherwise provides, in the absence of the Chairman of the Board, in the event of his inability or refusal
to act, or in the event of a vacancy in the office of the Chairman of the Board, the President shall perform the duties of the Chairman
of the Board, and when so acting shall have all the powers of and be subject to all the restrictions upon the Chairman of the Board.
Unless the Board of Directors otherwise provides, in the absence of the Chief Executive Officer or in the event of his or her inability
or refusal to act, or in the event of a vacancy in the office of the Chief Executive Officer, the President shall perform the duties
of the Chief Executive Officer, and when so acting shall have all the powers of and be subject to all the restrictions upon the Chief
Executive Officer. The President shall have authority, subject to such rules as may be prescribed by the Board of Directors, to
appoint such agents and employees of the corporation as he or she shall deem necessary, to prescribe their powers, duties and compensation,
and to delegate authority to them. He or she shall have authority to sign, execute and acknowledge, on behalf of the corporation, all
deeds, mortgages, bonds, stock certificates, contracts, leases, reports and all other documents or instruments necessary or proper to
be executed in the course of the corporation's regular business, or which shall be authorized by resolution of the Board of Directors;
and, except as otherwise provided by law or the Board of Directors, he or she may authorize any Vice President or other officer or agent
of the corporation to sign, execute and acknowledge such documents or instruments in his or her place and stead. In general he or she
shall perform all duties incident to the office of the President and such other duties as may be prescribed by the Board of Directors
from time to time.
Section 9. Vice-Presidents.
The Vice-President, or if there shall be more than one, the Vice-Presidents in the order determined by the Board of Directors, shall,
in the absence or disability of the President, act with all of the powers and be subject to all the restrictions of the President. The
Vice-Presidents shall also perform such other duties and have such other powers as the Board of Directors, the Chief Executive Officer
or these By-laws may, from time to time, prescribe.
Section 10. The
Secretary and Assistant Secretaries. The Secretary shall attend all meetings of the Board of Directors, all meetings of the
committees thereof and all meetings of the stockholders and record all the proceedings of the meetings in a book or books to be kept
for that purpose. Under the Chief Executive Officer's supervision, the Secretary shall give, or cause to be given, all notices required
to be given by these By-laws or by law; shall have such powers and perform such duties as the Board of Directors, the Chief Executive
Officer or these By-laws may, from time to time, prescribe; and shall have custody of the corporate seal of the corporation. The Secretary,
or an Assistant Secretary, shall have authority to affix any corporate seal to any instrument requiring it and when so affixed, it may
be attested by his or her signature or by the signature of such Assistant Secretary. The Board of Directors may give general authority
to any other officer to affix the seal of the corporation and to attest the affixing by his or her signature. The Assistant Secretary,
or if there be more than one, the Assistant Secretaries in the order determined by the Board of Directors, shall, in the absence or disability
of the Secretary, perform the duties and exercise the powers of the Secretary and shall perform such other duties and have such other
powers as the Board of Directors, the Chief Executive Officer or the Secretary may, from time to time, prescribe.
Section 11. The
Treasurer and Assistant Treasurer. The Treasurer shall have the custody of the corporate funds and securities; shall keep
full and accurate accounts of receipts and disbursements in books belonging to the corporation; shall deposit all monies and other valuable
effects in the name and to the credit of the corporation as may be ordered by the Board of Directors; shall cause the funds of the corporation
to be disbursed when such disbursements have been duly authorized, taking proper vouchers for such disbursements; and shall render to
the Chief Executive Officer and the Board of Directors, at its regular meeting or when the Board of Directors so requires, an account
of the corporation; shall have such powers and perform such duties as the Board of Directors, the Chief Executive Officer or these By-laws
may, from time to time, prescribe. If required by the Board of Directors, the Treasurer shall give the corporation a bond (which shall
be rendered every six (6) years) in such sums and with such surety or sureties as shall be satisfactory to the Board of Directors
for the faithful performance of the duties of the office of Treasurer and for the restoration to the corporation, in case of death, resignation,
retirement, or removal from office, of all books, papers, vouchers, money, and other property of whatever kind in the possession or under
the control of the Treasurer belonging to the corporation. The Assistant Treasurer, or if there shall be more than one, the Assistant
Treasurers in the order determined by the Board of Directors, shall in the absence or disability of the Treasurer, perform the duties
and exercise the powers of the Treasurer. The Assistant Treasurers shall perform such other duties and have such other powers as the
Board of Directors, the Chief Executive Officer or Treasurer may, from time to time, prescribe.
Section 12. Other
Officers, Assistant Officers and Agents. Officers, assistant officers and agents, if any, other than those whose duties are
provided for in these By-laws, shall have such authority and perform such duties as may from time to time be prescribed by resolution
of the Board of Directors.
Section 13. Absence
or Disability of Officers. In the case of the absence or disability of any officer of the corporation and of any person hereby
authorized to act in such officer's place during such officer's absence or disability, the Board of Directors may by resolution delegate
the powers and duties of such officer to any other officer or to any director, or to any other person whom it may select.
ARTICLE V
INDEMNIFICATION OF OFFICERS, DIRECTORS AND OTHERS
Section 1. Nature
of Indemnity. Each person who was or is made a party or is threatened to be made a party to or is involved in any action,
suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a "proceeding"), by reason of the
fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer, of the corporation or
is or was serving at the request of the corporation as a director, officer, employee, fiduciary, or agent of another corporation or of
a partnership, joint venture, trust or other enterprise, shall be indemnified and held harmless by the corporation to the fullest extent
which it is empowered to do so unless prohibited from doing so by the General Corporation Law of the State of Delaware, as the same exists
or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the corporation to
provide broader indemnification rights than said law permitted the corporation to provide prior to such amendment) against all expense,
liability and loss (including attorneys' fees actually and reasonably incurred by such person in connection with such proceeding) and
such indemnification shall inure to the benefit of his or her heirs, executors and administrators; provided, however, that, except as
provided in Section 2 hereof, the corporation shall indemnify any such person seeking indemnification in connection with a proceeding
initiated by such person only if such proceeding was authorized by the board of directors of the corporation. The right to indemnification
conferred in this Article V shall be a contract right and, subject to Sections 2 and 5 hereof, shall include the right to be paid
by the corporation the expenses incurred in defending any such proceeding in advance of its final disposition. The corporation may, by
action of its board of directors, provide indemnification to employees and agents of the corporation with the same scope and effect as
the foregoing indemnification of directors and officers.
Section 2. Procedure
for Indemnification of Directors and Officers. Any indemnification of a director or officer of the corporation under Section 1
of this Article V or advance of expenses under Section 5 of this Article V shall be made promptly, and in any event
within 30 days, upon the written request of the director or officer. If a determination by the corporation that the director or officer
is entitled to indemnification pursuant to this Article V is required, and the corporation fails to respond within sixty days to
a written request for indemnity, the corporation shall be deemed to have approved the request. If the corporation denies a written request
for indemnification or advancing of expenses, in whole or in part, or if payment in full pursuant to such request is not made within
30 days, the right to indemnification or advances as granted by this Article V shall be enforceable by the director or officer
in any court of competent jurisdiction. Such person's costs and expenses incurred in connection with successfully establishing his or
her right to indemnification, in whole or in part, in any such action shall also be indemnified by the corporation. It shall be a defense
to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its
final disposition where the required undertaking, if any, has been tendered to the corporation) that the claimant has not met the standards
of conduct which make it permissible under the General Corporation Law of the State of Delaware for the corporation to indemnify the
claimant for the amount claimed, but the burden of such defense shall be on the corporation. Neither the failure of the corporation (including
its board of directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such
action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct
set forth in the General Corporation Law of the State of Delaware, nor an actual determination by the corporation (including its board
of directors, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard of conduct, shall
be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.
Section 3. Article Not
Exclusive. The rights to indemnification and the payment of expenses incurred in defending a proceeding in advance of its
final disposition conferred in this Article V shall not be exclusive of any other right which any person may have or hereafter
acquire under any statute, provision of the certificate of incorporation, by-law, agreement, vote of stockholders or disinterested directors
or otherwise.
Section 4. Insurance.
The corporation may purchase and maintain insurance on its own behalf and on behalf of any person who is or was a director, officer,
employee, fiduciary, or agent of the corporation or was serving at the request of the corporation as a director, officer, employee or
agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him or her
and incurred by him or her in any such capacity, whether or not the corporation would have the power to indemnify such person against
such liability under this Article V.
Section 5. Expenses.
Expenses incurred by any person described in Section 1 of this Article V in defending a proceeding shall be paid by the corporation
in advance of such proceeding's final disposition unless otherwise determined by the board of directors in the specific case upon receipt
of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that he or she
is not entitled to be indemnified by the corporation. Such expenses incurred by other employees and agents may be so paid upon such terms
and conditions, if any, as the board of directors deems appropriate.
Section 6. Employees
and Agents. Persons who are not covered by the foregoing provisions of this Article V and who are or were employees
or agents of the corporation, or who are or were serving at the request of the corporation as employees or agents of another corporation,
partnership, joint venture, trust or other enterprise, may be indemnified to the extent authorized at any time or from time to time by
the board of directors.
Section 7. Contract
Rights. The provisions of this Article V shall be deemed to be a contract right between the corporation and each director
or officer who serves in any such capacity at any time while this Article V and the relevant provisions of the General Corporation
Law of the State of Delaware or other applicable law are in effect, and any repeal or modification of this Article V or any such
law shall not affect any rights or obligations then existing with respect to any state of facts or proceeding then existing.
Section 8. Merger
or Consolidation. For purposes of this Article V, references to "the corporation" shall include, in addition
to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or
merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees
or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving
at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture,
trust or other enterprise, shall stand in the same position under this Article V with respect to the resulting or surviving corporation
as he or she would have with respect to such constituent corporation if its separate existence had continued.
ARTICLE VI
CERTIFICATES OF STOCK; RECORD DATE
Section 1. Form.
The shares of the Company shall be uncertificated, provided that the Board of Directors may provide by resolution or resolutions that
some or all of any or all classes or series of its stock shall be certificated shares. Unless otherwise provided by resolution of the
Board of Directors, every holder of stock represented by certificates shall be entitled to have a certificate signed by, or in the name
of, the Company by any two officers of the Company representing the number of shares registered in certificate form. Any or all of the
signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile
signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued,
it may be issued by the Company with the same effect as if such person were such officer, transfer agent or registrar at the date of
issue. The Company shall not have power to issue a certificate in bearer form.
Section 2. Fixing
a Record Date for Stockholder Meetings. In order that the corporation may determine the stockholders entitled to notice of
or to vote at any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date, which record date
shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date
shall not be more than sixty (60) nor less than ten (10) days before the date of such meeting. If no record date is fixed by the
Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall
be the close of business on the next day preceding the day on which notice is given, or if notice is waived, at the close of business
on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to
vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix
a new record date for the adjourned meeting.
Section 3. Fixing
a Record Date for Action by Written Consent. In order that the corporation may determine the stockholders entitled to consent
to corporate action in writing without a meeting, the Board of Directors may fix a record date, which record date shall not precede the
date upon which the resolution fixing the record date is adopted by the Board of Directors, and which date shall not be more than ten
(10) days after the date upon which the resolution fixing the record date is adopted by the Board of Directors. If no record date
has been fixed by the Board of Directors, the record date for determining stockholders entitled to consent to corporate action in writing
without a meeting, when no prior action by the Board of Directors is required by statute, shall be the first date on which a signed written
consent setting forth the action taken or proposed to be taken is delivered to the corporation by delivery to its registered office in
the State of Delaware, its principal place of business, or an officer or agent of the corporation having custody of the book in which
proceedings of meetings of stockholders are recorded. Delivery made to the corporation's registered office shall be by hand or by certified
or registered mail, return receipt requested. If no record date has been fixed by the Board of Directors and prior action by the Board
of Directors is required by statute, the record date for determining stockholders entitled to consent to corporate action in writing
without a meeting shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior
action.
Section 4. Fixing
a Record Date for Other Purposes. In order that the corporation may determine the stockholders entitled to receive payment
of any dividend or other distribution or allotment or any rights or the stockholders entitled to exercise any rights in respect of any
change, conversion or exchange of stock, or for the purposes of any other lawful action, the Board of Directors may fix a record date,
which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall
be not more than sixty (60) days prior to such action. If no record date is fixed, the record date for determining stockholders for any
such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.
Section 5. Registered
Stockholders. Prior to the surrender to the corporation of the certificate or certificates for a share or shares of stock
with a request to record the transfer of such share or shares, the corporation may treat the registered owner as the person entitled
to receive dividends, to vote, to receive notifications, and otherwise to exercise all the rights and powers of an owner. The corporation
shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person,
whether or not it shall have express or other notice thereof.
Section 6. Subscriptions
for Stock. Unless otherwise provided for in the subscription agreement, subscriptions for shares shall be paid in full at
such time, or in such installments and at such times, as shall be determined by the Board of Directors. In case of default in the payment
of any installment or call when such payment is due, the corporation may proceed to collect the amount due in the same manner as any
debt due the corporation.
ARTICLE VII
GENERAL PROVISIONS
Section 1. Dividends.
Dividends upon the capital stock of the corporation, subject to the provisions of the certificate of incorporation, if any, may be declared
by the Board of Directors at any regular or special meeting, pursuant to law. Dividends may be paid in cash, in property, or in shares
of the capital stock, subject to the provisions of the certificate of incorporation. Before payment of any dividend, there may be set
aside out of any funds of the corporation available for dividends such sum or sums as the directors from time to time, in their absolute
discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining
any property of the corporation, or any other purpose and the directors may modify or abolish any such reserve in the manner in which
it was created.
Section 2. Checks,
Drafts or Orders. All checks, drafts, or other orders for the payment of money by or to the corporation and all notes and
other evidences of indebtedness issued in the name of the corporation shall be signed by such officer or officers, agent or agents of
the corporation, and in such manner, as shall be determined by resolution of the Board of Directors or a duly authorized committee thereof.
Section 3. Contracts.
The Board of Directors may authorize any officer or officers, or any agent or agents, of the corporation to enter into any contract or
to execute and deliver any instrument in the name of and on behalf of the corporation, and such authority may be general or confined
to specific instances.
Section 4. Loans.
The corporation may lend money to, or guarantee any obligation of, or otherwise assist any officer or other employee of the corporation
or of its subsidiary, including any officer or employee who is a director of the corporation or its subsidiary, whenever, in the judgment
of the directors, such loan, guaranty or assistance may reasonably be expected to benefit the corporation. The loan, guaranty or other
assistance may be with or without interest, and may be unsecured, or secured in such manner as the Board of Directors shall approve,
including, without limitation, a pledge of shares of stock of the corporation. Nothing in this section contained shall be deemed to deny,
limit or restrict the powers of guaranty or warranty of the corporation at common law or under any statute.
Section 5. Fiscal
Year. The fiscal year of the corporation shall be fixed by resolution of the Board of Directors.
Section 6. Corporate
Seal. The Board of Directors shall provide a corporate seal which shall be in the form of a circle and shall have inscribed
thereon the name of the corporation and the words "Corporate Seal, Delaware". The seal may be used by causing it or a facsimile
thereof to be impressed or affixed or reproduced or otherwise.
Section 7. Voting
Securities Owned By Corporation. Voting securities in any other corporation held by the corporation shall be voted by the
Ranking Officer, unless the Board of Directors specifically confers authority to vote with respect thereto, which authority may be general
or confined to specific instances, upon some other person or officer. Any person authorized to vote securities shall have the power to
appoint proxies, with general power of substitution.
Section 8. Inspection
of Books and Records. Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under
oath stating the purpose thereof, have the right during the usual hours for business to inspect for any proper purpose the corporation's
stock ledger, a list of its stockholders, and its other books and records, and to make copies or extracts therefrom. A proper purpose
shall mean any purpose reasonably related to such person's interest as a stockholder. In every instance where an attorney or other agent
shall be the person who seeks the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other
writing which authorizes the attorney or other agent to so act on behalf of the stockholder. The demand under oath shall be directed
to the corporation at its registered office in the State of Delaware or at its principal place of business.
Section 9. Section Headings.
Section headings in these By-laws are for convenience of reference only and shall not be given any substantive effect in limiting
or otherwise construing any provision herein.
Section 10. Inconsistent
Provisions. In the event that any provision of these By-laws is or becomes inconsistent with any provision of the certificate
of incorporation, the General Corporation Law of the State of Delaware, the Stockholders Agreements or any other applicable law, the
provision of these By-laws shall not be given any effect to the extent of such inconsistency but shall otherwise be given full force
and effect. Each Reference to the Stockholders Agreements shall be given effect only at such times as a Stockholders Agreements is then
in effect.
ARTICLE VIII
AMENDMENTS
These By-laws may be amended, altered, or repealed
and new By-laws adopted at any meeting of the Board of Directors by a majority vote. The fact that the power to adopt, amend, alter, or
repeal the By-laws has been conferred upon the Board of Directors shall not divest the stockholders of the same power.
v3.24.3
Cover
|
Sep. 16, 2024 |
Cover [Abstract] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Sep. 16, 2024
|
Current Fiscal Year End Date |
--12-31
|
Entity File Number |
001-34703
|
Entity Registrant Name |
ALIMERA SCIENCES, INC.
|
Entity Central Index Key |
0001267602
|
Entity Tax Identification Number |
20-0028718
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
6310 Town Square
|
Entity Address, Address Line Two |
Suite 400
|
Entity Address, City or Town |
Alpharetta
|
Entity Address, State or Province |
GA
|
Entity Address, Postal Zip Code |
30005
|
City Area Code |
678
|
Local Phone Number |
990-5740
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common Stock, $0.01 par value per share
|
Trading Symbol |
ALIM
|
Security Exchange Name |
NASDAQ
|
Entity Emerging Growth Company |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Alimera Sciences (NASDAQ:ALIM)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Alimera Sciences (NASDAQ:ALIM)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025